Pharmacokinetics and pharmacodynamics of doxycycline in a Streptococcus eq ui subsp. zooepidemicus infection model in horses
Autor: | Fabienne D Uehlinger, Patricia M. Dowling, Ron Johnson, Ronan J. J. Chapuis, Joe S. Smith, Melissa D. Meachem |
---|---|
Rok vydání: | 2021 |
Předmět: |
040301 veterinary sciences
Cmax Administration Oral Microbial Sensitivity Tests Pharmacology Doxycycline Hyclate Agar dilution 0403 veterinary science 03 medical and health sciences Minimum inhibitory concentration Pharmacokinetics Oral administration Animals Streptococcus equi Medicine Horses 0303 health sciences General Veterinary 030306 microbiology business.industry Horse 04 agricultural and veterinary sciences Anti-Bacterial Agents Doxycycline Pharmacodynamics business |
Zdroj: | Journal of Veterinary Pharmacology and Therapeutics. 44:766-775 |
ISSN: | 1365-2885 0140-7783 |
DOI: | 10.1111/jvp.12982 |
Popis: | The objectives of this study were to investigate the pharmacokinetics (PK), pharmacodynamics (PD), and the efficacy of oral administration of doxycycline (DXC) in horses with Streptococcus zooepidemicus tissue infections. Tissue chambers (TC) were implanted subcutaneously in the cervical region of 7 horses and inoculated with a single S. zooepidemicus isolate with a minimum inhibitory concentration (MIC) of 0.25 µg/ml, determined by agar dilution. Doxycycline hyclate (10 mg/kg, orally, q 12 h, for 5 days) mixed with poloxamer gel was started following inoculation. The TC fluid was sampled prior to and following inoculation for cytology analysis, quantitative culture, and DXC determination. Plasma DXC concentrations were measured over 48 h following the last dose of DXC administered. The mean plasma peak concentration (Cmax ) of DXC was 0.32 µg/ml, and concentrations above the MIC were only reached in 3 TC samples. In plasma, mean T > MIC was 2.4 h, mean Cmax /MIC was 1.30, and mean AUClast /MIC was 11.63 h. These PK/PD indices did not reach the suggested targets for DXC treatments of infections, and the TC abscessed in all horses. This is the first study to evaluate the recommended dose of DXC in horse in an infection model. |
Databáze: | OpenAIRE |
Externí odkaz: |